Main > ONCOLOGY (**) > Thyroid Cancer>Medullary>MET *** > Treatment > USA. E. c-MET Modulator Capsules

---

USA. E. c-MET Modulator Capsules's subsections
(*) USA Approval Date: 2012. 11.29
Company
Generic Name: Cabozantinib
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 10
Patent>UpDate: 2022. 07.12.
RTM
RTM Web-Site

USA. E. c-MET Modulator Capsules's products
This section has no products